Edition:
India

Apellis Pharmaceuticals Inc (APLS.OQ)

APLS.OQ on NASDAQ Stock Exchange Global Select Market

19.10USD
24 May 2019
Change (% chg)

$-0.37 (-1.90%)
Prev Close
$19.47
Open
$19.59
Day's High
$19.84
Day's Low
$18.83
Volume
69,261
Avg. Vol
94,501
52-wk High
$24.78
52-wk Low
$11.45

About

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. The Company's lead compounds are designed to inhibit complement component 3 (C3), the central protein in the complement cascade. The... (more)

Overall

Beta: --
Market Cap(Mil.): $1,207.74
Shares Outstanding(Mil.): 63.23
Dividend: --
Yield (%): --

Financials

  APLS.OQ Industry Sector
P/E (TTM): -- 31.10 35.45
EPS (TTM): -2.77 -- --
ROI: -68.89 12.04 11.75
ROE: -88.38 13.35 16.50

Earnings vs. Estimates